Dezhou People's Hospital
13
4
4
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 13 trials
100.0%
+13.5% vs industry average
15%
2 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
Effect of Predictive Model on Double-Balloon Enteroscopy
Role: collaborator
A Research Protocol for Evaluating the Efficacy of Perfused Chemotherapeutic Agents for Bladder Cancer Based on Organoid Technology
Role: collaborator
Stroke Registration of Young Adults in China
Role: collaborator
Effects of COVID-19 Infection on Pregnancy Outcomes and Offspring Health
Role: collaborator
Clinical Study of UCB Combined With UC-MSCs in the Treatment of Bone Marrow Failure Disorders
Role: collaborator
China Research for Severe Spontaneous Intracerebral Hemorrhage（CRISIH）
Role: collaborator
SPT-07A Injection in Patients With Acute Ischemic Stroke (AIS): A Phase III Clinical Trial
Role: collaborator
The Study About the Selection of Time for Retreatment of Helicobacter Pylori After Eradication Failure
Role: collaborator
The Study on the Selection of Time for Retreatment of Helicobacter Pylori After Eradication Failure
Role: collaborator
WASP Classification in Diagnosis of Diminutive Colorectal Polyps
Role: collaborator
Nutritional Management in Respiratory Critically Ill Patients -an Observational Study in Mainland China
Role: collaborator
Evaluation of Antithrombotic STrategies in STEMI Patients in China
Role: collaborator
Clinical Utility Of Genetic Screening For HLA-B*1301, On Susceptibility To Dapsone Hypersensitivity Syndrome
Role: collaborator
All 13 trials loaded